Drug Shortage Report for VIRAZOLE
Report ID | 213468 |
Drug Identification Number | 02170140 |
Brand name | VIRAZOLE |
Common or Proper name | VIRAZOLE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | RIBAVIRIN |
Strength(s) | 6G |
Dosage form(s) | POWDER FOR SOLUTION AEROSOL |
Route of administration | INHALATION INHALATION |
Packaging size | 4's |
ATC code | J05AP |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-12-07 |
Estimated end date | 2024-01-23 |
Actual end date | 2024-01-22 |
Shortage status | Resolved |
Updated date | 2024-01-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-01-29 | French | Compare |
v9 | 2024-01-29 | English | Compare |
v8 | 2024-01-25 | French | Compare |
v7 | 2024-01-25 | English | Compare |
v6 | 2024-01-22 | French | Compare |
v5 | 2024-01-22 | English | Compare |
v4 | 2024-01-10 | French | Compare |
v3 | 2024-01-10 | English | Compare |
v2 | 2023-12-15 | French | Compare |
v1 | 2023-12-15 | English | Compare |
Showing 1 to 10 of 10